We studied regional patterns of thyroid cancer incidence in relation to iodine intake and iodinization in Sweden using 5,838 incident cases diagnosed in the period 1958-1981. Region was defined either by iodine status, urban-rural status or healthcare region (internal controls). Age, period and coho
Trends in thyroid cancer incidence in Sweden, 1958–1981, by histopathologic type
✍ Scribed by Bo Pettersson; Hans-Olov Adami; Erik Wilander; Michel P. Coleman
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- French
- Weight
- 591 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Time trends in the incidence of malignant neoplasms of the thyroid were examined for Sweden for the period 1958–81, 5, 838 cases being studied. Autopsy‐diagnosed cases were excluded. Mean annual changes in the age‐standardized rates over this period were 1.9% and 1.2% for women and men, respectively, for all thyroid carcinomas combined; 4.9% and 2.1 % for papillary carcinoma; 0.9% and 2.1 % for follicular carcinoma; and − 1.0% and −2.1 % for anaplastic carcinoma. Age, period and cohort models were fitted. There was a progressive increase in papillary cancer incidence for cohorts born since 1919. This increase cannot be satisfactorily explained as an artefact of trends in classification, and probably reflects a real increase in incidence. A less marked increase was seen for follicular cancer, and there was a decline for cohorts born since 1939. While the risk of papillary and anaplastic carcinoma was lower in iodine‐deficient areas, follicular cancer risk was twice as high in these areas, for men only. There was a steady decline of anaplastic cancer in both sexes after 1965, largely attributable to a decline in cohorts born since 1924.
📜 SIMILAR VOLUMES
## Abstract Lung cancer is a major public health concern worldwide. Our study aims to examine trends in incidence of lung cancer in Scotland during 1959–97 and by histologic type for 1975–97. In Scotland, lung cancer is the most commonly diagnosed cancer in men and is the second most commonly diagn